T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response

Corey Smith(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Sweera Rehan(QIMR Berghofer Medical Research Institute), Katherine Matthews, Matthew D. Solomon(Sutter Health), Dillon Corvino(University of Bonn), Daniel C. Chambers(Prince Charles Hospital), Ross S. Francis, Michelle A. Neller(QIMR Berghofer Medical Research Institute), Scott B. Campbell(The University of Queensland), Leone Beagley, Laëtitia Le Texier(QIMR Berghofer Medical Research Institute), Pauline Crooks(QIMR Berghofer Medical Research Institute)
Journal of Clinical Investigation
August 15, 2019
10.1172/jci128323
Cited by 24

Related Papers

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
|Blood|2006|250
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|Proceedings of the National Academy of Sciences|2004|235
BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies
|Clinical Microbiology Reviews|2017|226